Sertraline-induced periorbital purpura: a case report.

CONCLUSION: Abnormal bleeding after treatment with an SSRI should be kept in mind, and alternative non-SSRI drugs of choice in such cases would be more appropriate. More extensive and comprehensive studies focusing on hemostasis and bleeding disorders are needed for SSRIs such as sertraline. PMID: 25964653 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25964653?dopt=Abstract

Source: Australasian Psychiatry - May 11, 2015 Category: Psychiatry Authors: Kayhan F, Eken ZE, Uguz F Tags: Australas Psychiatry Source Type: research